Purity Specifications, Storage and Distribution for Medications Development
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026R00136
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN22
Additional Details
Documents1
The National Institutes of Health (NIH), specifically through the National Institute on Drug Abuse (NIDA), has issued a Special Notice seeking information from qualified small businesses regarding their capabilities to support the development of medications through the provision of purity specifications, storage, and distribution services. This notice, identified by procurement number 75N98026R00136, is a Sources Sought announcement intended solely for information gathering and planning purposes; it does not constitute a solicitation for proposals, abstracts, or quotations, nor does it obligate the government to any contractual commitment.
The primary objective of this initiative is to establish a centralized repository capable of receiving, inventorying, analyzing, and securely storing chemical and biological compounds. These compounds may originate from a variety of sources, including domestic and international investigators, commercial entities, and pharmaceutical companies. The repository must be equipped to handle materials prepared under both Good Manufacturing Practices (GMP) and non-GMP conditions, with storage capacities ranging from milligram quantities to several kilograms.
A critical requirement for participation in this project is compliance with the Controlled Substances Act of 1970. The selected entity must possess, or be able to obtain, DEA Research Registration for handling controlled substances classified under Schedules II to V, and potentially Schedule I. This ensures that all activities related to controlled substances are conducted in accordance with federal regulations.
The scope of work encompasses the following key tasks:
- Serving as a centralized holding site for a diverse array of chemical and biological compounds.
- Maintaining comprehensive inventory and analytical records for all stored materials.
- Providing secure storage solutions that accommodate both GMP and non-GMP materials in varying quantities.
- Ensuring full regulatory compliance, particularly with respect to controlled substances.
The place of performance for this effort is Bethesda, Maryland, within the United States. The applicable NAICS code is 541715, which covers Research and Development in the Physical, Engineering, and Life Sciences (excluding Nanotechnology and Biotechnology). The Product Service Code is AN22.
This notice is issued by the Department of Health and Human Services, National Institutes of Health. Interested parties are encouraged to review the attached documentation for further details and to submit capability statements by the specified response date. The primary point of contact for this notice is Polina Klimenkova, who can be reached at [email protected].
Contractors considering this opportunity should note that this is a market research effort focused on identifying small businesses with the requisite expertise, infrastructure, and regulatory credentials to support NIDA’s medications development program. The government is particularly interested in entities with demonstrated experience in the secure handling, storage, and distribution of controlled substances, as well as the ability to manage a wide range of compound types and quantities.
For additional information and to access the official notice, please refer to the SAM.gov opportunity at: https://sam.gov/opp/de59e3aea58d42f7a64eb45185acdd2d/view.